Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 574 of 5804
-
New weekly shot shows promise for major weight loss in obesity trial
Disease control CompletedThis study is open to adults who are at least 18 years old and have * a body mass index (BMI) of 30 kg/m² or more, or * a BMI of 27 kg/m² or more and at least one health problem related to their weight. People with type 2 diabetes cannot take part in this study. Only people who…
Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New heart valve trial hopes to offer less invasive option for aortic stenosis patients
Disease control TerminatedThe EMPIRE II study evaluates the safety and performance of the entire ALLEGRA THV System. The primary safety endpoint is composite of all-cause mortality or stroke rates at 12 months. And the primary performance endpoint is device success at 7 days. Based on the outcomes of a …
Phase: NA • Sponsor: NVT GmbH • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Experimental drug targets Hard-to-Treat brain metastases
Disease control CompletedThe goal of this phase II clinical trial\] is to analyze the efficacy of patritumab deruxtecan (HER3-DXd) in patients with metastatic breast cancer (MBC) or advanced non-small cell lung cancer (aNSCLC) with active brain metastases (BM) who have received at least one line of syste…
Phase: PHASE2 • Sponsor: MedSIR • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Human milk mouth care may shield preemies from lung infections
Disease control Recruiting nowPremature infants are susceptible to complications related to infrequent and non-standardized oral care. Although the benefits of frequent standardized oral care are known to reduce oral dysbiosis (increased level of potentially pathogenic bacteria) and its associated complicatio…
Phase: NA • Sponsor: University of Florida • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New shot aims to wipe out myeloma in patients out of options
Disease control OngoingThe goal of this phase II, open-label, single-arm, multicenter study is to evaluate i) the efficacy and ii) safety of elranatamab monotherapy at the dose of 76 mg subcutaneously in participants with RRMM after at least one or two prior lines of therapy who have received prior tre…
Phase: PHASE2 • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New blood test could slash unnecessary antibiotics in fragile newborns
Diagnosis Recruiting nowLate-onset neonatal sepsis (LOS), occurring in newborn of at least 7 days of life, is frequently observed in Neonatal Intensive Care Units (NICUs) and potentially severe (mortality, neurologic and respiratory impairments). Despite its high prevalence, a reliable diagnostic remai…
Sponsor: Hospices Civils de Lyon • Aim: Diagnosis
Last updated Jun 26, 2026 12:44 UTC
-
New heart valve could offer lifeline for patients with failing artificial valves
Disease control Recruiting nowThe objective of this study is to establish the safety and effectiveness of the Edwards SAPIEN X4 Transcatheter Heart Valve (THV) in subjects who are at high or greater risk with a failing aortic bioprosthetic valve.
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New shot could ease back pain for ankylosing spondylitis patients
Disease control CompletedThis is a randomized, double-blind, placebo-controlled, multi-center phase III clinical study to evaluate the efficacy and safety of AK111 in the treatment of subjects with active ankylosing spondylitis.
Phase: PHASE3 • Sponsor: Akeso • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New hope: eye injections may stop Radiation-Related blindness
Prevention Recruiting nowThis randomized controlled trial will evaluate the effect of intravitreal faricimab or fluocinolone acetonide (FAc) intravitreal implant compared with observation on long-term visual acuity following treatment of choroidal melanoma with iodine-125 plaque brachytherapy.
Phase: PHASE3 • Sponsor: Jaeb Center for Health Research • Aim: Prevention
Last updated Jul 18, 2026 00:00 UTC
-
Blood test hunt for silent killer: 5,000 High-Risk volunteers sought
Diagnosis Recruiting nowThe purpose of this research is to see if adding blood-based tests and symptom review to standard-of-care pancreatic cancer screening procedures can identify cancer early among individuals with increased risk.
Phase: EARLY_PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
One-Week radiation after breast cancer surgery could be just as good, with better looks
Disease control Recruiting nowThe primary objective of this study is to determine in women with node negative BC ≤3cm in size, if PBI compared to WBI, both given once-a-day over 1 week following BCS, is non-inferior for LR and reduces adverse cosmesis. The primary outcomes are LR and patient-assessed cosmesis…
Phase: PHASE3 • Sponsor: Ontario Clinical Oncology Group (OCOG) • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New Weight-Loss drug survodutide tested in 5,500+ people for heart safety
Disease control CompletedThis study is open to adults who are at least 18 years old and have a body mass index (BMI) of 27 kg/m2 or more. People can take part if they have cardiovascular or chronic kidney disease. People who have at least 2 health problems related to their weight or risks of cardiovascul…
Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New drug duo aims to tackle Hard-to-Treat breast cancer
Disease control OngoingThis research study is being done to evaluate the safety and effectiveness of sacituzumab govitecan with trastuzumab (Herceptin, Herceptin Hylecta, or trastuzumab biosimilar) in metastatic HER2+ breast cancer. The names of the study drugs used in this research study are: * Saci…
Phase: PHASE2 • Sponsor: Adrienne G. Waks • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Blood test may spot liver cancer recurrence before scans do
Diagnosis Recruiting nowThis study will conduct a prospective cohort study to verify the predictive value of ctDNA-MRD longitudinal monitoring model in predicting postoperative recurrence, verify whether ctDNA-MRD longitudinal monitoring model can indicate recurrence earlier than imaging examination, an…
Sponsor: Zhujiang Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
New study tests therapy to save homeless youth from suicide
Symptom relief Recruiting nowSuicide is the leading cause of death among YEH and most youth do not access services that may be available to them. Therefore, this study seeks to address this gap in the research literature with the goal to identify an effective intervention that can be readily adopted by commu…
Phase: NA • Sponsor: Ohio State University • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
New combo aims to boost esophageal cancer treatment before surgery
Disease control Recruiting nowThis phase II trial tests how well preoperative (prior to surgery) radiation therapy with fluorouracil, oxaliplatin, and leucovorin calcium (FOLFOX) works for the treatment of stage I-III esophageal or gastroesophageal junction adenocarcinoma. Hypofractionated radiation therapy d…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New device aims to improve survival and reduce hospital stays for lung clot patients
Disease control OngoingThis study is a prospective, multicenter, randomized controlled trial of the FlowTriever System plus anticoagulation compared to anticoagulation alone for intermediate-risk acute PE.
Phase: NA • Sponsor: Inari Medical • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New drug combo aims to shrink lung tumors before surgery
Disease control Recruiting nowThis is a randomized, controlled, double-blind, multicenter Phase 3 clinical study to assess the efficacy and safety of envafolimab plus platinum-based doublet chemotherapy versus placebo plus platinum-based doublet chemotherapy as neoadjuvant/adjuvant therapy in subjects with re…
Phase: PHASE3 • Sponsor: 3D Medicines (Sichuan) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could a Drug-Radiation combo tame brain tumors?
Disease control TerminatedTo determine the safety and efficacy of using the drug azeliragon combined with stereotactic radiosurgery. Specifically, to determine if this combination will lead to improved response in the brain (tumor shrinking in size) and overall tumor control (how long tumor remains contro…
Phase: PHASE1, PHASE2 • Sponsor: Baptist Health South Florida • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New combo shows promise for rare kidney cancers
Disease control OngoingThis is a Phase Ib/II, open-label, single arm trial to evaluate the efficacy and safety of AK104 in combination with axitinib as a first-line treatment for advanced/metastatic special pathological subtypes of renal cell carcinoma (ssRCC). Subjects will receive AK104 plus axitinib…
Phase: PHASE1, PHASE2 • Sponsor: Hao Zeng • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC